Literature DB >> 819227

Beclomethasone dipropionate and chronic asthma. The effect of long-term aerosol administration on the hypothalamic-pituitary-adrenal axis after substitution for oral therapy with corticosteroids.

S A Spitzer, H Kaufman, A Koplovitz, M Topilsky, I Blum.   

Abstract

Beclomethasone dipropionate aerosol at a dose of 100 mug four times a day was administered to 32 patients suffering from chronic perennial asthma. Twenty-three of these patients had previously received prolonged treatment with corticosteroids, causing various degrees of adrenal suppression in some patients. Almost complete recovery of adrenal function was observed within a period of six months in most patients. Treatment with beclomethasone dipropionate did not affect the hypothalamic-pituitary-adrenal axis in the other nine asthmatic patients who had not received prolonged corticosteroid therapy previously and who served as a control group.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819227     DOI: 10.1378/chest.70.1.38

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Safety and efficacy of long-term treatment with inhaled beclomethasone dipropionate in steroid-dependent asthma.

Authors:  I Broder; S M Tarlo; G M Davies; P Thomas; A Leznoff; J Sturgess; R Baumal; S Mintz; P N Corey
Journal:  CMAJ       Date:  1987-01-15       Impact factor: 8.262

Review 2.  The place of high-dose inhaled corticosteroids in asthma therapy.

Authors:  M J Smith
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

Review 3.  Adrenal corticosteroids in the treatment of asthma.

Authors:  S C Siegel
Journal:  Clin Rev Allergy       Date:  1983-03

Review 4.  Inhaled corticosteroids in children. Is there a 'safe' dosage?

Authors:  A L Boner; G L Piacentini
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

5.  Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function.

Authors:  M J Smith; M E Hodson
Journal:  Thorax       Date:  1983-09       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.